SCHEMBL105486

Kakonein is a lipid of Polyketides (PK) class. Kakonein is associated with abnormalities such as Fatty Liver, Chronic liver disease, Morphologically altered structure, Hypertensive disease and Cardiovascular Diseases. The involved functions are known as protein expression, Extravasation, Liver damage, mRNA Expression and cell activation. Kakonein often locates in Body tissue, Hepatic, Microvilli, Cytoplasm and Membrane. The associated genes with Kakonein are TJP1 gene, CD14 gene, iberiotoxin, AT-Rich Interactive Domain-Containing Protein 1A and NKS1 gene. The related lipids are dehydrosoyasaponin I and Steroids. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of SCHEMBL105486, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with SCHEMBL105486?

SCHEMBL105486 is suspected in Chronic liver disease, Hypertensive disease, Cardiovascular Diseases, Myocardial Infarction, Cerebrovascular accident, Fatty Liver and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with SCHEMBL105486

MeSH term MeSH ID Detail
Liver Cirrhosis D008103 67 associated lipids
Memory Disorders D008569 33 associated lipids
Parkinson Disease D010300 53 associated lipids
Urinary Incontinence D014549 4 associated lipids
Reperfusion Injury D015427 65 associated lipids
Glucose Intolerance D018149 13 associated lipids
Alcohol-Related Disorders D019973 3 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Neurotoxicity Syndromes D020258 34 associated lipids
Per page 10 20 50 | Total 43

PubChem Associated disorders and diseases

What pathways are associated with SCHEMBL105486

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with SCHEMBL105486?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with SCHEMBL105486?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with SCHEMBL105486?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with SCHEMBL105486?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with SCHEMBL105486?

Knock-out

Knock-out are used in the study 'MATE2 mediates vacuolar sequestration of flavonoid glycosides and glycoside malonates in Medicago truncatula.' (Zhao J et al., 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with SCHEMBL105486

Download all related citations
Per page 10 20 50 100 | Total 919
Authors Title Published Journal PubMed Link
Zhu X et al. The effect of puerarin against IL-1β-mediated leukostasis and apoptosis in retinal capillary endothelial cells (TR-iBRB2). 2014 Mol. Vis. pmid:25593509
Hou JY et al. Mucoadhesive microparticles for gastroretentive delivery: preparation, biodistribution and targeting evaluation. 2014 Mar Drugs pmid:25470180
Tiyasatkulkovit W et al. Pueraria mirifica extract and puerarin enhance proliferation and expression of alkaline phosphatase and type I collagen in primary baboon osteoblasts. 2014 Phytomedicine pmid:25442257
Li B et al. Puerarin enhances bone mass by promoting osteoblastogenesis and slightly lowering bone marrow adiposity in ovariectomized rats. 2014 Biol. Pharm. Bull. pmid:25590084
Xie N et al. Puerarin protects hippocampal neurons against cell death in pilocarpine-induced seizures through antioxidant and anti-apoptotic mechanisms. 2014 Cell. Mol. Neurobiol. pmid:25151533
Maji AK et al. Pueraria tuberosa: a review on its phytochemical and therapeutic potential. 2014 Nat. Prod. Res. pmid:24980468
Ma JQ et al. Puerarin ameliorates carbon tetrachloride-induced oxidative DNA damage and inflammation in mouse kidney through ERK/Nrf2/ARE pathway. 2014 Food Chem. Toxicol. pmid:24975872
Wang C et al. The proliferation, differentiation, and mineralization effects of puerarin on osteoblasts in vitro. 2014 Chin J Nat Med pmid:24969524
Wei SY et al. Progress on the pharmacological research of puerarin: a review. 2014 Chin J Nat Med pmid:24969520
Park WS et al. Anti-graying effect of the extract of Pueraria thunbergiana via upregulation of cAMP/MITF-M signaling pathway. 2014 J. Dermatol. Sci. pmid:24924521
Yu P et al. Determination of puerarin in rat plasma using PEGylated magnetic carbon nanotubes by high performance liquid chromatography. 2014 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:24768919
Kim SB et al. In vitro and in vivo evaluation of the effect of puerarin on hepatic cytochrome p450-mediated drug metabolism. 2014 Planta Med. pmid:24710899
Lu XL et al. Protective effects of puerarin against Aß40-induced vascular dysfunction in zebrafish and human endothelial cells. 2014 Eur. J. Pharmacol. pmid:24690262
Liu S et al. Puerarin alleviates aggravated sympathoexcitatory response induced by myocardial ischemia via regulating P2X3 receptor in rat superior cervical ganglia. 2014 Neurochem. Int. pmid:24657446
Zhou A et al. Lymphatic transport of puerarin occurs after oral administration of different lipid-based formulations to unconscious lymph duct-cannulated rats. 2014 Pharm Dev Technol pmid:23978005
Wang JW et al. Puerarin ameliorates oxidative stress in a rodent model of traumatic brain injury. 2014 J. Surg. Res. pmid:24079811
Yuan Y et al. Puerarin attenuates pressure overload-induced cardiac hypertrophy. 2014 J Cardiol pmid:23906530
Liao ZG et al. Transport properties of puerarin and effect of extract of Radix Angelicae dahuricae on puerarin intestinal absorption using in situ and in vitro models. 2014 Phytother Res pmid:24756954
Lu Q et al. Puerarin attenuates calcification of vascular smooth muscle cells. 2014 Am. J. Chin. Med. pmid:24707866
Wang Y et al. Simultaneous determination of four components in Baige capsule by HPLC: application to pharmacokinetics and tissue distribution of normal and middle cerebral artery occlusion rats. 2014 Biomed. Chromatogr. pmid:24122939